Boston Scientific Corporation (NYSE: BSX) today announced that it has acquired Labcoat Limited, a privately held, development-stage drug-eluting stent technology ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE